Appletree

Appletree CI Group was a specialized clinical research organization (CRO) providing comprehensive clinical development services to the pharmaceutical, biotechnology, and medical device industries. The company was particularly recognized for its deep expertise in niche therapeutic areas, including ophthalmology, pediatrics, and medical devices. Headquartered in Switzerland, it operated across several European countries, offering services ranging from regulatory affairs and clinical trial management to medical writing and quality assurance. In 2018, the company was acquired by Pharm-Olam to expand its global footprint and specialized therapeutic capabilities.